2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid CAS 178306-51-9 Purity ≥99.0% (HPLC) Factory

Tsanangudzo Pfupi

Zita: 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid

CAS: 178306-51-9

Chitarisiko: White kana Off-White Powder

Kuchena: ≥99.0% (HPLC)

Pakati pe (CAS: 177036-94-1) mukurapa kwePulmonary Arterial Hypertension (PAH)

Inquiry: alvin@ruifuchem.com

Tumira email kwatiri

Product Detail

Product Tags

Tsanangudzo:

Commercial Supply (CAS: 177036-94-1) Vanopindirana:
CAS: 177036-94-1
Methyl 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoate CAS: 178306-47-3
2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid CAS: 178306-51-9
(S)-2-Hydroxy-3-Methoxy-3,3-Diphenylpropionic Acid CAS: 178306-52-0
L-Proline Methyl Ester Hydrochlorid CAS: 2133-40-6
4,6-Dimethyl-2-(Methylsulfonyl)pyrimidine CAS: 35144-22-0

Chemical Properties:

Chemical Name	2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid
Nhamba yeCAS	178306-51-9
Nhamba yeCAT	RF-PI161
Stock Status	MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula	C16H16O4
Molecular Weight	272.3
Density	1.248
Brand	Ruifu Chemical

Zvinotsanangurwa:

Item	Zvinotsanangurwa
Chitarisiko	White kana Off-White Powder
Kuchena	≥99.0% (HPLC)
Kunyorova (KF)	≤1.00%
Kusachena Kumwechete	≤0.50%
Zvose Zvisina Kuchena	≤1.00%
Test Standard	Enterprise Standard
Usage	Yepakati pe API (CAS: 177036-94-1)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. ndiyo inotungamira mugadziri uye mutengesi we2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid (CAS: 178306-51-9) ine mhando yepamusoro, ndiyo kiyi yepakati yeAPI (CAS. : 177036-94-1).(CAS: 177036-94-1)inosarudza endothelin-A (ETA) receptor antagonist yakaunzwa pamuromo kurapwa kwevarwere vane pulmonary arterial hypertension (PAH), kuvandudza kugona kwekuita uye kunonoka kuwedzera kwekiriniki.Ndiyo yechitatu ET-receptor antagonist kuti atengeswe ichi chiratidzo kuseri kwebosentan uye sitaxsentan.PAH chirwere chisingawanzoitiki chemagetsi maduku emapapu anoratidzwa nekuwedzera kwevascular uye kugadzirisa, zvichiita kuti kuwedzera kunowedzera mumapapu ekudzivirira kwevascular uye pulmonary arterial pressure, uye pakupedzisira, kukundikana kwe ventricular uye kufa nguva isati yakwana.Zviratidzo zvekutanga zvePAH zvinosanganisira zvishoma nezvishoma kutanga kupfupika kwekufema, kuneta, kufema, edema, uye kupera simba.